NEW YORK, Nov. 04, 2022 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following public companies. You can see a copy of the complaints by visiting the links below or you can contact Peretz Bronstein, Esq. or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you have suffered damage, you can request that the court appoint you as lead plaintiff. Your ability to participate in a recovery does not require you to serve as lead plaintiff. A lead plaintiff acts on behalf of all other group members in conducting the litigation. The lead plaintiff can select a law firm of his choice. An investor’s ability to participate in a potential future recovery is not contingent on its serving as lead plaintiff.

Sema4 Holdings Corp. (NASDAQ: SMFR, SMFRW)
school lesson: March 14, 2022 – August 15, 2022
Meeting: November 7, 2022
For more information: www.bgandg.com/smfr
The Complaint filed in this Class Action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and failed to disclose material adverse facts about the Company’s business, operations and prospects. Specifically, Defendants failed to disclose to investors: (1) that there was a significant risk that Sema4 would reverse a substantial amount of previously recognized revenue that it was unable to recover from third-party payers; (2) that the company experienced decreasing selling prices for its reproductive health segment; (3) that Sema4’s financial results would be adversely affected as a result of the foregoing; and (4) that as a result of the foregoing, defendants’ positive statements about the Company’s business, operations and prospects were materially misleading and/or lacked any reasonable basis.

Medtronic plc (NYSE:MDT)
school lesson: June 8, 2019 – May 25, 2022
Meeting: 7.11….